📣 VC round data is live. Check it out!
- Public Comps
- HLB Life Science
HLB Life Science Valuation Multiples
Discover revenue and EBITDA valuation multiples for HLB Life Science and similar public comparables like Berry Corp, LGI Ltd., La Francaise de l'Energie, Beetaloo Energy Australia and more.
HLB Life Science Overview
About HLB Life Science
HLB Life Science Co Ltd and its subsidiaries are engaged in the medicare business, bio development business, medical device business, and drug distribution business. The company is a medical device for in vitro diagnostics.The main business is the Medicare business, which includes foot and manufacturing, quasi-drug component development, and finished product consignment production.
Founded
1998
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$350M
Valuation Multiples
Start free trialHLB Life Science Financials
HLB Life Science reported last fiscal year revenue of $30M and negative EBITDA of ($55M).
In the same fiscal year, HLB Life Science generated ($327K) in gross profit, ($55M) in EBITDA losses, and had net loss of ($66M).
HLB Life Science P&L
In the most recent fiscal year, HLB Life Science reported revenue of $30M and EBITDA of ($55M).
HLB Life Science is unprofitable as of last fiscal year, with gross margin of (1%), EBITDA margin of (183%), and net margin of (218%).
Financial data powered by Morningstar, Inc.
HLB Life Science Stock Performance
HLB Life Science has current market cap of $254M, and enterprise value of $350M.
Market Cap Evolution
HLB Life Science's stock price is $2.09.
HLB Life Science share price decreased by 4.1% in the last 30 days, and by 37.4% in the last year.
HLB Life Science has an EPS (earnings per share) of $-0.54.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $350M | $254M | -5.5% | -4.1% | -19.1% | -37.4% | $-0.54 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHLB Life Science Valuation Multiples
HLB Life Science trades at 11.6x EV/Revenue multiple, and (6.3x) EV/EBITDA.
HLB Life Science Financial Valuation Multiples
As of June 3, 2026, HLB Life Science has market cap of $254M and EV of $350M.
HLB Life Science has a P/E ratio of (3.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HLB Life Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


HLB Life Science Margins & Growth Rates
In the most recent fiscal year, HLB Life Science reported gross margin of (1%), EBITDA margin of (183%), and net margin of (218%).
HLB Life Science Margins
HLB Life Science Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
HLB Life Science Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
HLB Life Science Competitors
HLB Life Science competitors include Berry Corp, LGI Ltd., La Francaise de l'Energie, Beetaloo Energy Australia, Infinity Natural Resources, Horizon Oil, Montauk Renewables, Omega Oil & Gas, Imperial Ptrl and Archer.
Most HLB Life Science public comparables operate across Energy Production.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| 9.3x | 7.9x | 19.6x | 15.8x | |||
| 9.3x | 8.7x | 17.5x | 22.9x | |||
| 58.4x | 49.8x | (21.3x) | (237.7x) | |||
| 2.0x | 1.5x | 2.8x | 2.1x | |||
| 2.6x | 2.6x | 11.9x | - | |||
| 2.1x | 2.0x | 10.6x | 8.5x | |||
| 3751.8x | 11402.9x | (59.0x) | (32.1x) | |||
This data is available for Pro users. Sign up to see all HLB Life Science competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HLB Life Science
| When was HLB Life Science founded? | HLB Life Science was founded in 1998. |
| Where is HLB Life Science headquartered? | HLB Life Science is headquartered in South Korea. |
| Is HLB Life Science publicly listed? | Yes, HLB Life Science is a public company listed on Korea Exchange. |
| What is the stock symbol of HLB Life Science? | HLB Life Science trades under 067630 ticker. |
| When did HLB Life Science go public? | HLB Life Science went public in 2008. |
| Who are competitors of HLB Life Science? | HLB Life Science main competitors include Berry Corp, LGI Ltd., La Francaise de l'Energie, Beetaloo Energy Australia, Infinity Natural Resources, Horizon Oil, Montauk Renewables, Omega Oil & Gas, Imperial Ptrl, Archer. |
| What is the current market cap of HLB Life Science? | HLB Life Science's current market cap is $254M. |
| What is the current revenue of HLB Life Science? | HLB Life Science's last fiscal year revenue is $30M. |
| What is the current EV/Revenue multiple of HLB Life Science? | Current revenue multiple of HLB Life Science is 11.6x. |
| Is HLB Life Science profitable? | No, HLB Life Science is not profitable. |
| How many companies HLB Life Science has acquired to date? | HLB Life Science hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies HLB Life Science has invested to date? | HLB Life Science hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to HLB Life Science
Lists including HLB Life Science
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.